|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 209/08 | (2006.01) |
| C07D 209/08 | (2013.01) | ||
| A61K 31/403 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/14 | (2018.01) |
| (11) | Number of the document | 3630723 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18728541.6 |
| Date of filing the European patent application | 2018-05-18 | |
| (97) | Date of publication of the European application | 2020-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2018/063028 |
| Date | 2018-05-18 |
| (87) | Number | WO 2018/215315 |
| Date | 2018-11-29 |
| (30) | Number | Date | Country code |
| 17172237 | 2017-05-22 | EP |
| (72) |
BONFANTI, Jean-François , FR
KESTELEYN, Bart, Rudolf, Romanie , BE
BARDIOT, Dorothée, Alice, Marie-Eve , BE
MARCHAND, Arnaud, Didier, M , BE
COESEMANS, Erwin , BE
FORTIN, Jérôme, Michel, Claude , FR
MERCEY, Guillaume, Jean, Maurice , FR
RABOISSON, Pierre, Jean-Marie, Bernard , BE
|
| (73) |
Janssen Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
Katholieke Universiteit Leuven , Waaistraat 6, Bus 5105, 3000 Leuven, BE |
| (54) | SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |
| SUBSTITUTED INDOLINE DERIVATIVES AS DENGUE VIRAL REPLICATION INHIBITORS |